ReviewHematology, transfusion and cell therapy

Ponatinib in the treatment of patients with chronic myeloid leukemia and increased cardiovascular risk: A review of management strategies.

Tomasz Sacha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.